BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 27919945)

  • 1. The Leloir Pathway of Galactose Metabolism - A Novel Therapeutic Target for Hepatocellular Carcinoma.
    Tang M; Etokidem E; Lai K
    Anticancer Res; 2016 Dec; 36(12):6265-6271. PubMed ID: 27919945
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Galactose-1 phosphate uridylyltransferase (GalT) gene: A novel positive regulator of the PI3K/Akt signaling pathway in mouse fibroblasts.
    Balakrishnan B; Chen W; Tang M; Huang X; Cakici DD; Siddiqi A; Berry G; Lai K
    Biochem Biophys Res Commun; 2016 Jan; 470(1):205-212. PubMed ID: 26773505
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The molecular basis of galactosemia - Past, present and future.
    Timson DJ
    Gene; 2016 Sep; 589(2):133-41. PubMed ID: 26143117
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Galactose 1-phosphate accumulates to high levels in galactose-treated cells due to low GALT activity and absence of product inhibition of GALK.
    Oh SL; Cheng LY; J Zhou JF; Henke W; Hagen T
    J Inherit Metab Dis; 2020 May; 43(3):529-539. PubMed ID: 31774565
    [TBL] [Abstract][Full Text] [Related]  

  • 5. GalR Acts as a Transcriptional Activator of galKT in the Presence of Galactose in Streptococcus pneumoniae.
    Afzal M; Shafeeq S; Manzoor I; Kuipers OP
    J Mol Microbiol Biotechnol; 2015; 25(6):363-71. PubMed ID: 26544195
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential roles of the Leloir pathway enzymes and metabolites in defining galactose sensitivity in yeast.
    Ross KL; Davis CN; Fridovich-Keil JL
    Mol Genet Metab; 2004; 83(1-2):103-16. PubMed ID: 15464425
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intracellular galactose-1-phosphate accumulation leads to environmental stress response in yeast model.
    Slepak T; Tang M; Addo F; Lai K
    Mol Genet Metab; 2005 Nov; 86(3):360-71. PubMed ID: 16169270
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The occurrence of the Leloir pathway in non-pathogenic mycobacteria.
    Szumiło T
    Acta Microbiol Pol; 1981; 30(4):327-33. PubMed ID: 6179392
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Overexpression of human UDP-glucose pyrophosphorylase rescues galactose-1-phosphate uridyltransferase-deficient yeast.
    Lai K; Elsas LJ
    Biochem Biophys Res Commun; 2000 May; 271(2):392-400. PubMed ID: 10799308
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Arenobufagin, a natural bufadienolide from toad venom, induces apoptosis and autophagy in human hepatocellular carcinoma cells through inhibition of PI3K/Akt/mTOR pathway.
    Zhang DM; Liu JS; Deng LJ; Chen MF; Yiu A; Cao HH; Tian HY; Fung KP; Kurihara H; Pan JX; Ye WC
    Carcinogenesis; 2013 Jun; 34(6):1331-42. PubMed ID: 23393227
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regulatory effects of galactose on galactose-1-phosphate uridyltransferase activity on human hepatoblastoma HepG2 cells.
    Davit-Spraul A; Pourci ML; Ng KH; Soni T; Lemonnier A
    FEBS Lett; 1994 Nov; 354(2):232-6. PubMed ID: 7957929
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diagnosis of inherited disorders of galactose metabolism.
    Cuthbert C; Klapper H; Elsas L
    Curr Protoc Hum Genet; 2008 Jan; Chapter 17():Unit 17.5. PubMed ID: 18428423
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular basis of disorders of human galactose metabolism: past, present, and future.
    Novelli G; Reichardt JK
    Mol Genet Metab; 2000; 71(1-2):62-5. PubMed ID: 11001796
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A case-control study of galactose consumption and metabolism in relation to ovarian cancer.
    Cramer DW; Greenberg ER; Titus-Ernstoff L; Liberman RF; Welch WR; Li E; Ng WG
    Cancer Epidemiol Biomarkers Prev; 2000 Jan; 9(1):95-101. PubMed ID: 10667469
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Suppressive effects of microRNA-16 on the proliferation, invasion and metastasis of hepatocellular carcinoma cells.
    Wu WL; Wang WY; Yao WQ; Li GD
    Int J Mol Med; 2015 Dec; 36(6):1713-9. PubMed ID: 26499886
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Toxicity of 2-deoxygalactose to Saccharomyces cerevisiae cells constitutively synthesizing galactose-metabolizing enzymes.
    Platt T
    Mol Cell Biol; 1984 May; 4(5):994-6. PubMed ID: 6328283
    [TBL] [Abstract][Full Text] [Related]  

  • 17. D-galactose catabolism in Penicillium chrysogenum: Expression analysis of the structural genes of the Leloir pathway.
    Jónás Á; Fekete E; Németh Z; Flipphi M; Karaffa L
    Acta Biol Hung; 2016 Sep; 67(3):318-32. PubMed ID: 27630054
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of the enzymatic activities of human galactokinase GALK1 and a related human galactokinase protein GK2.
    Ai Y; Basu M; Bergsma DJ; Stambolian D
    Biochem Biophys Res Commun; 1995 Jul; 212(2):687-91. PubMed ID: 7542884
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Terminal sugars in glycoconjugates: metabolism of free and protein-bound L-fucose, N-acetylneuraminic acid and D-galactose in liver and Morris hepatomas.
    Reutter W; Bauer C
    Adv Exp Med Biol; 1977 May 22-24; 92():405-37. PubMed ID: 205106
    [No Abstract]   [Full Text] [Related]  

  • 20. Subcellular localization of galactose-1-phosphate uridylyltransferase in the yeast Saccharomyces cerevisiae.
    Christacos NC; Marson MJ; Wells L; Riehman K; Fridovich-Keil JL
    Mol Genet Metab; 2000 Aug; 70(4):272-80. PubMed ID: 10993714
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.